A digital toolkit with patient scripts, risk calculator comparisons and more could help primary care and OB/GYN providers ...
The FDA has approved berotralstat oral pellets for prophylactic use in patients aged 2 to than 12 years with hereditary ...
Being a physician is a privilege because your skills can truly change a life.Restoring sight gives someone back their ...
Is omission of the sentinel lymph node biopsy safe in early breast cancer in patients treated with breast conserving therapy ...
For the first time in nearly 40 years, the FDA approved a new antibiotic to treat gonorrhea, an STI that has grown ...
In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, professor and chairman of ...
More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...
In this video, Shazia K. Nakhoda, MD, discusses a study that showed time-limited triple combination therapy with pirtobrutinib yielded ‘favorable’ results in patients with chronic lymphocytic leukemia ...
Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...
A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...
The FDA is proposing to add bemotrizinol to the list of permitted active ingredients for use in sunscreens, according to a ...
A mobile health tool used to serially monitor patients through patient-reported outcomes could significantly improve quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results